Core Insights - QuidelOrtho aims to enhance diagnostic excellence by repurposing and certifying high-performing analyzers to improve access to reliable diagnostic technology for healthcare facilities in underserved communities [1][3] - The certification process for analyzers includes over 140 system checks, functional adjustments, hardware cleaning or replacement, and extensive performance testing, ensuring alignment with QuidelOrtho's quality and performance criteria [1][2] - The program features certified VITROS XT 7600 and 5600 Integrated Systems and the VITROS 3600 Immunodiagnostic System, designed to support community labs with general chemistries, immunoassay tests, and drug screening [2] Company Overview - QuidelOrtho Corporation (Nasdaq: QDEL) is a leader in in vitro diagnostics, focusing on developing intelligent solutions that transform data into actionable insights for a broader audience [4] - The company specializes in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, providing fast, accurate, and reliable diagnostics across various settings [4][5] - QuidelOrtho is committed to advancing diagnostics and improving healthcare outcomes through innovation and collaboration with global healthcare customers [5]
QuidelOrtho Launches Certified Analyzer Program